Elixi, Author at Elixi International - Page 9 of 13

3 February 2020

FDA approves first drug for treatment of peanut allergy for children

0 Comments4 Minutes

23 January 2020

The combination of lopinavir/ritonavir and interferon-beta- 1b shows good results against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

0 Comments3 Minutes

15 January 2020

Enhertu (fam-trastuzumab deruxtecan-nxki), new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

0 Comments3 Minutes

13 January 2020

Padcev (enfortumab vedotin-ejfv), a new type of therapy to treat advanced urothelial cancer

0 Comments3 Minutes

9 January 2020

Lynparza (olaparib), already licensed for breast and ovarian cancer,it’s set to become the world’s first precision medicine for prostate cancer.

0 Comments2 Minutes

9 January 2020

Phorbiplatin, a new “on-site” activated anti-tumor prodrug that effectively kills cancer cells minimizing damage to normal tissues.

0 Comments5 Minutes

11 December 2019

First generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS)

0 Comments3 Minutes

26 November 2019

MiSight, first contact lens indicated to slow the progression of nearsightedness in children

0 Comments4 Minutes

20 November 2019

Descovy (emtricitabine and tenofovir alafenamide) drug to prevent HIV infection

0 Comments5 Minutes

19 November 2019

Ervebo, First vaccine to protect against Ebola

0 Comments5 Minutes